Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $601,357 - $788,379
10,687 New
10,687 $738,000
Q2 2022

Aug 15, 2022

SELL
$35.61 - $76.23 $147,389 - $315,515
-4,139 Reduced 32.65%
8,537 $336,000
Q1 2022

May 16, 2022

BUY
$57.56 - $82.54 $729,630 - $1.05 Million
12,676 New
12,676 $886,000
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $4.31 Million - $5.84 Million
-47,670 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$89.51 - $118.04 $4.27 Million - $5.63 Million
47,670 New
47,670 $5.63 Million
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $3.87 Million - $6.46 Million
-80,200 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$37.84 - $69.96 $597,872 - $1.11 Million
-15,800 Reduced 16.46%
80,200 $4.8 Million
Q1 2018

May 15, 2018

BUY
$39.82 - $57.53 $3.82 Million - $5.52 Million
96,000 New
96,000 $3.87 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Quantitative Investment Management, LLC Portfolio

Follow Quantitative Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Investment Management, LLC with notifications on news.